Results per Page:
Going straight to the source in defense against infant RSV
New anti-idiotype antibody a first step in possible strategy to build infant immunity during vulnerable window
Infectious disease scientists look beyond the pandemic
A symposium about protecting people with weakened immune systems from microbial threats
Cross-neutralizing Monoclonal Antibodies Against Respiratory Viruses
From the Boonyaratanakornkit, Taylor and Pancera labs, Vaccine and Infectious Disease Division and Cancer Immunology Program, Cancer Consortium
Two rare antibodies, one drug, four viruses
Researchers discover antibodies to block RSV, other viruses that put transplant patients at risk
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Sleuthing the immune system’s mysterious T-regs
Dr. Jennifer Lund probes why regulatory T cells show up when trouble comes around
SARS-CoV-2 variants of concern break through vaccination barriers
From the University of Washington and the Fred Hutch Vaccine and Infectious Disease Division
Preparing for coronavirus in your community
As experts warn of a pandemic, here's what you can do
Forecasting the shape of flu viruses to come
‘Deep mutational scanning’ to make a better flu vaccine
What we can learn about global flu evolution from individual infections
Study of 10-year-old flu samples finds virus’s evolution in individual transplant patients partially mirrors later global trends
First test of 'off-the-shelf' cord blood cell product outside the transplantation setting
Celebrating faculty and staff achievements
Experts from leading cancer centers ask, ‘Where’s the outcry?’
Antiviral drug for post-transplant complications now costs more than the transplant
When flu viruses join forces
Certain influenza variants infect cells better together than apart, new study shows